FUOM

gene
On this page

Also known as FLJ26016FucUFucM

Summary

FUOM (fucose mutarotase, HGNC:24733) is a protein-coding gene on chromosome 10q26.3, encoding Fucose mutarotase (A2VDF0). Involved in the interconversion between alpha- and beta-L-fucoses.

Predicted to enable L-fucose mutarotase activity and fucose binding activity. Predicted to be involved in GDP-L-fucose salvage; fucose metabolic process; and fucosylation. Predicted to act upstream of or within female mating behavior and negative regulation of neuron differentiation. Predicted to be active in cytosol.

Source: NCBI Gene 282969 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 33 total
  • MANE Select transcript: NM_001098483

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:24733
Approved symbolFUOM
Namefucose mutarotase
Location10q26.3
Locus typegene with protein product
StatusApproved
AliasesFLJ26016, FucU, FucM
Ensembl geneENSG00000148803
Ensembl biotypeprotein_coding
OMIM617725
Entrez282969

Gene structure

Transcript identifiers

Ensembl transcripts: 13 — 11 protein_coding, 2 protein_coding_CDS_not_defined

ENST00000278025, ENST00000368551, ENST00000368552, ENST00000447176, ENST00000465384, ENST00000478895, ENST00000850601, ENST00000863239, ENST00000863240, ENST00000863241, ENST00000863242, ENST00000916332, ENST00000916333

RefSeq mRNA: 4 — MANE Select: NM_001098483 NM_001098483, NM_001301827, NM_001301828, NM_198472

CCDS: CCDS44499, CCDS76364, CCDS7680

Canonical transcript exons

ENST00000278025 — 6 exons

ExonStartEnd
ENSE00001304268133355158133355436
ENSE00003569089133356640133356738
ENSE00003579291133357187133357255
ENSE00003606447133356943133357013
ENSE00003678039133355738133355811
ENSE00003769574133357923133358019

Expression profiles

Bgee: expression breadth ubiquitous, 183 present calls, max score 98.24.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.5997 / max 193.6965, expressed in 1703 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
1121269.24251683
1121232.0015822
1121250.243865
1121240.111830

Top tissues by expression

247 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right lobe of liverUBERON:000111498.24gold quality
liverUBERON:000210795.65gold quality
ileal mucosaUBERON:000033191.13gold quality
small intestine Peyer’s patchUBERON:000345489.57gold quality
duodenumUBERON:000211489.44gold quality
kidney epitheliumUBERON:000481988.94silver quality
adult mammalian kidneyUBERON:000008288.87gold quality
small intestineUBERON:000210888.87gold quality
cortex of kidneyUBERON:000122588.45gold quality
mucosa of transverse colonUBERON:000499188.42gold quality
tibial nerveUBERON:000132388.41gold quality
granulocyteCL:000009488.07gold quality
spleenUBERON:000210687.68gold quality
monocyteCL:000057687.47gold quality
leukocyteCL:000073887.25gold quality
right atrium auricular regionUBERON:000663186.51gold quality
metanephros cortexUBERON:001053385.60gold quality
cardiac atriumUBERON:000208185.39gold quality
kidneyUBERON:000211385.01gold quality
left coronary arteryUBERON:000162684.85gold quality
apex of heartUBERON:000209884.85gold quality
thoracic aortaUBERON:000151584.10gold quality
ascending aortaUBERON:000149684.01gold quality
coronary arteryUBERON:000162183.94gold quality
descending thoracic aortaUBERON:000234583.88gold quality
lower esophagus mucosaUBERON:003583483.81gold quality
saliva-secreting glandUBERON:000104483.71gold quality
vermiform appendixUBERON:000115483.64gold quality
mucosa of stomachUBERON:000119983.58gold quality
transverse colonUBERON:000115783.55gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-GEOD-125970yes71.77
E-ANND-3yes5.02
E-MTAB-6386no67.48

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

11 targeting FUOM, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-3605-5P99.9667.12932
HSA-MIR-471999.7372.103329
HSA-MIR-613299.6065.831554
HSA-MIR-6836-5P99.6065.621538
HSA-MIR-6722-3P99.4567.621919
HSA-MIR-544B99.1867.411632
HSA-MIR-1909-3P99.0366.561662
HSA-MIR-367097.8864.39763
HSA-MIR-873-3P96.8466.09786
HSA-MIR-391896.1364.651300

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriofuomENSDARG00000039422
mus_musculusFuomENSMUSG00000025466
rattus_norvegicusFuomENSRNOG00000018476

Protein

Protein identifiers

Fucose mutarotaseA2VDF0 (reviewed: A2VDF0)

All UniProt accessions (3): A2VDF0, X6R6T9, X6RK00

UniProt curated annotations — full annotation on UniProt →

Function. Involved in the interconversion between alpha- and beta-L-fucoses. L-Fucose (6-deoxy-L-galactose) exists as alpha-L-fucose (29.5%) and beta-L-fucose (70.5%), the beta-form is metabolized through the salvage pathway. GDP-L-fucose formed either by the de novo or salvage pathways is transported into the endoplasmic reticulum, where it serves as a substrate for N- and O-glycosylations by fucosyltransferases. Fucosylated structures expressed on cell surfaces or secreted in biological fluids are believed to play a critical role in cell-cell adhesion and recognition processes.

Subunit / interactions. Mainly homodimer, but also exists as homotetramer, homooctamer, and homodecamer. The homodimeric form seems catalytically inactive.

Pathway. Carbohydrate metabolism; L-fucose metabolism.

Similarity. Belongs to the RbsD / FucU family.

Isoforms (2)

UniProt IDNamesCanonical?
A2VDF0-11yes
A2VDF0-22

RefSeq proteins (4): NP_001091953, NP_001288756, NP_001288757, NP_940874 (=MANE)

Domains & families (InterPro)

IDNameType
IPR007721RbsD_FucUFamily
IPR023750RbsD-like_sfHomologous_superfamily
IPR050443RbsD/FucU_mutarotaseFamily

Pfam: PF05025

Enzyme classification (BRENDA):

  • EC 5.1.3.29 — L-fucose mutarotase (BRENDA: 5 organisms, 7 substrates, 0 inhibitors, 0 Km, 0 kcat entries)

Catalyzed reactions (Rhea), 1 shown:

  • alpha-L-fucose = beta-L-fucose (RHEA:25580)

UniProt features (12 total): binding site 5, active site 3, splice variant 2, chain 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A2VDF0-F196.770.95

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (3): 24 (proton donor); 69; 120

Ligand- & substrate-binding residues (5): 32; 79; 120; 138; 140

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-6787639GDP-fucose biosynthesis

MSigDB gene sets: 115 (showing top): GOBP_NEGATIVE_REGULATION_OF_NEURON_DIFFERENTIATION, GOBP_BEHAVIOR, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN, GOBP_NEUROGENESIS, GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, GOBP_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS, GOBP_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS, GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS, GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS, GOBP_REGULATION_OF_NEURON_DIFFERENTIATION, GOBP_CARBOHYDRATE_DERIVATIVE_BIOSYNTHETIC_PROCESS, GOBP_REPRODUCTIVE_BEHAVIOR, GOBP_CARBOHYDRATE_METABOLIC_PROCESS, GOBP_FUCOSE_METABOLIC_PROCESS

GO Biological Process (7): fucose metabolic process (GO:0006004), neuron differentiation (GO:0030182), GDP-L-fucose salvage (GO:0042352), negative regulation of neuron differentiation (GO:0045665), female mating behavior (GO:0060180), monosaccharide metabolic process (GO:0005996), obsolete fucosylation (GO:0036065)

GO Molecular Function (5): racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857), L-fucose mutarotase activity (GO:0036373), fucose binding (GO:0042806), isomerase activity (GO:0016853), monosaccharide binding (GO:0048029)

GO Cellular Component (1): cytosol (GO:0005829)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Synthesis of substrates in N-glycan biosythesis1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
hexose metabolic process1
cell differentiation1
generation of neurons1
GDP-L-fucose biosynthetic process1
metabolic compound salvage1
neuron differentiation1
negative regulation of cell differentiation1
regulation of neuron differentiation1
mating behavior1
carbohydrate metabolic process1
small molecule metabolic process1
racemase and epimerase activity1
racemase and epimerase activity, acting on carbohydrates and derivatives1
monosaccharide binding1
catalytic activity1
carbohydrate binding1
small molecule binding1
cytoplasm1
cellular anatomical structure1

Protein interactions and networks

STRING

194 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
FUOMDENND10Q8TCE6643
FUOMGALMQ96C23519
FUOMZNF511Q8NB15507
FUOMFUCA1P04066480
FUOMPRAP1Q96NZ9480
FUOMENOSF1Q7L5Y1472
FUOMHTATIP2Q9BUP3458
FUOMXYLBO75191453
FUOMSCART1Q4G0T1420
FUOMCALYQ9NYX4392
FUOMKRTAP11-1Q8IUC1384
FUOMSIAH1Q8IUQ4377
FUOMSLC35H1Q9NQQ7356
FUOMKRT17Q04695334
FUOMTESPA1A2RU30322

IntAct

7 interactions, top by confidence:

ABTypeScore
FUOMEEF1A2psi-mi:“MI:0914”(association)0.530
TAFA3FUOMpsi-mi:“MI:0914”(association)0.350
FUOMPRRC2Apsi-mi:“MI:0914”(association)0.350
UBA52FUOMpsi-mi:“MI:0914”(association)0.350
NUDCD1FUOMpsi-mi:“MI:0914”(association)0.350

BioGRID (25): FUOM (Affinity Capture-MS), MLLT4 (Affinity Capture-MS), EEA1 (Affinity Capture-MS), PRRC1 (Affinity Capture-MS), TOMM34 (Affinity Capture-MS), FRA10AC1 (Affinity Capture-MS), EEF1A2 (Affinity Capture-MS), GPALPP1 (Affinity Capture-MS), GOLGA3 (Affinity Capture-MS), PKN1 (Affinity Capture-MS), RBM27 (Affinity Capture-MS), RNF123 (Affinity Capture-MS), DDX46 (Affinity Capture-MS), PRRC2A (Affinity Capture-MS), FUOM (Affinity Capture-MS)

ESM2 similar proteins: A1A8Z3, A1JRP2, A2VDF0, A4TNS5, A4W892, A5F769, A7FKQ0, A7MTL8, A7ZJC5, A8GB96, A9R3A9, B1JSU6, B2K8Q8, B2TUY1, B2VBT3, B4SZF9, B4TC11, B5BC59, B5F034, B5QX27, B5R6A2, B6I7Q4, B7LAF1, B7M6B3, B7MGK7, B7MPN4, C3LND6, C6DCF2, P24519, Q0P563, Q0T6Y0, Q0TJV1, Q1CAE9, Q1CFN2, Q1REI1, Q2NUL1, Q2SCM1, Q32IH8, Q4ZW81, Q57RK0

Diamond homologs: A1AEZ1, A2VDF0, A3N2Y4, A5UAS6, A5UHL6, A6TD85, A7ZQP8, A8A3T9, A8AP17, A9MSA4, A9N2J4, B0BSB3, B0US22, B1IU37, B1LQZ8, B1VU78, B1XDL3, B2TZD0, B3H2T2, B4T4X3, B4TGN5, B4TUJ9, B5BF33, B5F4S5, B5FTY3, B5QWR2, B5RDV6, B5XUY2, B5Z4C4, B6I6K2, B7LEY4, B7LXM0, B7MLC5, B7MZA0, B7N738, B7NVV2, B7UHM0, B8F6Y2, C0PXG7, C3JZP4

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

33 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance29
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

956 predictions. Top by Δscore:

VariantEffectΔscore
10:133355810:CT:Cacceptor_gain1.0000
10:133356934:AG:Adonor_gain1.0000
10:133356934:AGC:Adonor_gain1.0000
10:133356935:G:Cdonor_gain1.0000
10:133356942:CCGGA:Cdonor_gain1.0000
10:133356950:T:Adonor_gain1.0000
10:133357009:CAGGC:Cacceptor_gain1.0000
10:133357010:AGGC:Aacceptor_gain1.0000
10:133357011:GGC:Gacceptor_gain1.0000
10:133357012:GC:Gacceptor_gain1.0000
10:133357012:GCC:Gacceptor_loss1.0000
10:133357013:CC:Cacceptor_gain1.0000
10:133357013:CCTGG:Cacceptor_loss1.0000
10:133357014:C:Aacceptor_loss1.0000
10:133357014:C:CCacceptor_gain1.0000
10:133357015:T:Cacceptor_loss1.0000
10:133357918:CTCA:Cdonor_loss1.0000
10:133357920:CAC:Cdonor_loss1.0000
10:133357921:A:ACdonor_gain1.0000
10:133357922:C:CCdonor_gain1.0000
10:133357922:C:CTdonor_loss1.0000
10:133357922:CCGAT:Cdonor_gain1.0000
10:133355808:CTCT:Cacceptor_gain0.9900
10:133355812:C:CCacceptor_gain0.9900
10:133356634:GCTTA:Gdonor_loss0.9900
10:133356635:CTTA:Cdonor_loss0.9900
10:133356636:TTACC:Tdonor_loss0.9900
10:133356638:ACC:Adonor_loss0.9900
10:133356735:CAGC:Cacceptor_gain0.9900
10:133356738:CCTAG:Cacceptor_loss0.9900

AlphaMissense

975 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
10:133355779:A:CF119L0.986
10:133355779:A:TF119L0.986
10:133355781:A:GF119L0.986
10:133357236:G:CF35L0.982
10:133357236:G:TF35L0.982
10:133357238:A:GF35L0.982
10:133355755:A:CF127L0.978
10:133355755:A:TF127L0.978
10:133355757:A:GF127L0.978
10:133355753:G:TA128D0.977
10:133357255:A:TV29D0.976
10:133355769:C:GA123P0.973
10:133355400:C:AK145N0.970
10:133355400:C:GK145N0.970
10:133355399:C:AG146W0.969
10:133355407:A:TL143H0.969
10:133355747:A:TV130E0.969
10:133355399:C:GG146R0.968
10:133355399:C:TG146R0.968
10:133355419:C:TG139E0.968
10:133355750:A:TV129D0.968
10:133355768:G:TA123D0.966
10:133355780:A:GF119S0.966
10:133357245:G:CD32E0.966
10:133357245:G:TD32E0.966
10:133357246:T:AD32V0.963
10:133357925:A:TI28N0.963
10:133355413:A:GL141P0.961
10:133355413:A:TL141H0.960
10:133355415:G:CN140K0.960

dbSNP variants (sampled 300 via entrez): RS1000589020 (10:133355566 C>T), RS1000958148 (10:133355309 G>A), RS1001017078 (10:133356910 A>C), RS1001713961 (10:133355037 C>T), RS1001746720 (10:133355235 C>A,G), RS1002517729 (10:133354201 T>G), RS1002592780 (10:133358034 C>A,G,T), RS1002789113 (10:133359811 G>A,T), RS1002970376 (10:133357754 A>G,T), RS1003392717 (10:133353721 G>A,T), RS1003423763 (10:133354101 G>A), RS1003794446 (10:133358518 G>A,T), RS1004068518 (10:133359189 C>T), RS1004502492 (10:133353218 G>C), RS1004533499 (10:133353434 C>T)

Disease associations

OMIM: gene MIM:617725 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST007250_1Nonunion in individuals with fractures2.000000e-08

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0009707fractures, ununited

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

34 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, increases expression3
Benzo(a)pyrenedecreases expression, increases methylation3
Arsenicaffects methylation, increases methylation2
Aflatoxin B1affects expression, decreases expression2
aristolochic acid Idecreases expression1
GSK-J4decreases expression1
methyleugenoldecreases expression1
propionaldehydeincreases expression1
bisphenol Aincreases methylation1
tris(2-butoxyethyl) phosphateaffects expression1
beta-lapachonedecreases expression, increases expression1
butyraldehydeincreases expression1
pentanalincreases expression1
jinfukangincreases expression1
Rosiglitazonedecreases expression1
Sunitinibdecreases expression1
Acetaminophendecreases expression1
Aldehydesincreases expression1
Diazinonincreases methylation1
Leadaffects methylation1
N-Nitrosopyrrolidinedecreases expression1
Smokedecreases expression1
Tobacco Smoke Pollutionincreases expression1
Tretinoindecreases expression1
Vanadatesincreases expression1
Cyclosporinedecreases expression1
Antirheumatic Agentsdecreases expression1
Cadmium Chlorideincreases expression1
Okadaic Aciddecreases expression1
Copper Sulfatedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.